NCT07894029
Effect of Neuromuscular Blocking Agent Use on Video Laryngeal Mask Airway Insertion
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (10)
Show 5 moreShow less
Arms and interventions
Patients assigned to this group will receive intravenous propofol (2-2.5 mg/kg), remifentanil (1 mcg/kg), and rocuronium (0.6 mg/kg) during anesthesia induction before video laryngeal mask airway placement. Sugammadex 200 mg IV will be administered at the end of surgery before device removal.
Patients assigned to this group will receive intravenous propofol (2-2.5 mg/kg) and remifentanil (1 mcg/kg) during anesthesia induction without administration of a neuromuscular blocking agent before video laryngeal mask airway placement.
Drugs: Rocuronium, Standard Anesthesia Induction (Propofol and Remifentanil)
Sites
1 site in 1 country
- Hacettepe University Faculty of Medicine HospitalAnkara, Ankara, Turkey (Türkiye)